CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Charlene Son Rigby of Global Genes Recognized as a 2026 Fierce 50 Honoree

Positive
AI Analysis

Summary

Global Genes CEO Charlene Son Rigby has been recognized as a 2026 Fierce 50 honoree for her work building infrastructure that centers rare disease patient advocates in drug development.

Importance:2/10
Sentiment:
0.30
rare diseasepatient advocacydrug developmentleadership recognition
Related Companies

Read the original article

Published by PR Newswire Pharma on September 2, 2026 1:00 PM

Read Original